Cyanotech appoints new president, CEO, director
Bailey will replace David Rosenthal, who has served as interim president and CEO since 27 February 2010. Rosenthal said that they were pleased that Bailey has chosen to
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The collaboration combines Bend Research’s advanced drug formulation capabilities and Quotient Clinical’s clinical-trial design service, RapidFACT (Rapid Formulation development And Clinical Testing). RapidFACT represents a new paradigm for